408 related articles for article (PubMed ID: 26418759)
41. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.
Yomtovian R; Niklinski W; Silver B; Sarode R; Tsai HM
Br J Haematol; 2004 Mar; 124(6):787-95. PubMed ID: 15009067
[TBL] [Abstract][Full Text] [Related]
42. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
[TBL] [Abstract][Full Text] [Related]
43. Thrombotic thrombocytopenic purpura and adult onset Still's disease.
Gopal M; Cohn CD; McEntire MR; Alperin JB
Am J Med Sci; 2009 May; 337(5):373-6. PubMed ID: 19322066
[TBL] [Abstract][Full Text] [Related]
44. Current concepts in thrombotic thrombocytopenic purpura.
Tsai HM
Annu Rev Med; 2006; 57():419-36. PubMed ID: 16409158
[TBL] [Abstract][Full Text] [Related]
45. Thrombotic thrombocytopenic purpura--the role of ADAMTS13 assay in clinical practice.
Duraković N; Radonić R; Gasparović V
Coll Antropol; 2010 Sep; 34(3):1087-91. PubMed ID: 20977108
[TBL] [Abstract][Full Text] [Related]
46. Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP.
Darabi K; Berg AH
Am J Clin Pathol; 2006 Apr; 125(4):592-7. PubMed ID: 16627268
[TBL] [Abstract][Full Text] [Related]
47. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features.
Reese JA; Muthurajah DS; Kremer Hovinga JA; Vesely SK; Terrell DR; George JN
Pediatr Blood Cancer; 2013 Oct; 60(10):1676-82. PubMed ID: 23729372
[TBL] [Abstract][Full Text] [Related]
48. Thrombotic thrombocytopenic purpura.
Kremer Hovinga JA; Coppo P; Lämmle B; Moake JL; Miyata T; Vanhoorelbeke K
Nat Rev Dis Primers; 2017 Apr; 3():17020. PubMed ID: 28382967
[TBL] [Abstract][Full Text] [Related]
49. [Thrombotic thrombocytopenic purpura].
Yoshitaka M
Rinsho Ketsueki; 2021; 62(5):430-434. PubMed ID: 34108326
[TBL] [Abstract][Full Text] [Related]
50. [Rituximab as effective therapy in very severe thrombotic thrombocytopenic purpura (TTP)].
Illner N; Wolf G
Dtsch Med Wochenschr; 2010 May; 135(3):71-4. PubMed ID: 20077379
[TBL] [Abstract][Full Text] [Related]
51. [New developments in treatment modalities of thrombotic thrombocytopenic purpura].
Matsumoto M
Rinsho Ketsueki; 2017; 58(10):2081-2086. PubMed ID: 28978852
[TBL] [Abstract][Full Text] [Related]
52. ADAMTS13 deficiency and thrombotic thrombocytopenic purpura associated with trimethoprim-sulfamethoxazole.
Bapani S; Epperla N; Kasirye Y; Mercier R; Garcia-Montilla R
Clin Med Res; 2013 Jun; 11(2):86-90. PubMed ID: 23262188
[TBL] [Abstract][Full Text] [Related]
53. Advantages and limits of ADAMTS13 testing in the prognostic assessment of thrombotic thrombocytopenic purpura.
Mannucci PM; Franchini M
Presse Med; 2012 Mar; 41(3 Pt 2):e157-62. PubMed ID: 22244722
[TBL] [Abstract][Full Text] [Related]
54. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.
Kalish Y; Rottenstreich A; Rund D; Hochberg-Klein S
J Thromb Thrombolysis; 2016 Aug; 42(2):155-60. PubMed ID: 26867546
[TBL] [Abstract][Full Text] [Related]
55. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor.
Schleinitz N; Ebbo M; Mazodier K; Poullin P; Bernit E; Veit V; Veyradier A; Fakhouri F; Kaplanski G; Harle JR
Am J Hematol; 2007 May; 82(5):417-8. PubMed ID: 17266057
[No Abstract] [Full Text] [Related]
56. Acute pancreatitis-induced thrombotic thrombocytopenic purpura with recurrent acute pancreatitis.
Fujino Y; Inoue Y; Onodera M; Kikuchi S; Sato M; Kojika M; Sato H; Suzuki K; Matsumoto M
Clin J Gastroenterol; 2016 Apr; 9(2):104-8. PubMed ID: 26905311
[TBL] [Abstract][Full Text] [Related]
57. Thrombotic Thrombocytopenic Purpura Treated with Rituximab Associated with Primary Sjögren's Syndrome and Primary Hypothyroidism.
Okumura T; Hashimoto K; Aomura D; Kurasawa Y; Hara Y; Fujii K; Masuda T; Sonoda K; Yamaguchi A; Ogawa Y; Kamijo Y
Intern Med; 2020 Mar; 59(5):715-719. PubMed ID: 31708547
[TBL] [Abstract][Full Text] [Related]
58. Atypical presentations of thrombotic thrombocytopenic purpura: a review.
Sarode R
J Clin Apher; 2009; 24(1):47-52. PubMed ID: 19073011
[TBL] [Abstract][Full Text] [Related]
59. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
[TBL] [Abstract][Full Text] [Related]
60. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
